Skip to main content
. 2016 Aug 29;11(8):e0161486. doi: 10.1371/journal.pone.0161486

Fig 8. Compound 8 and 6 synergize to reduce the viability of patient-derived glioma cell lines.

Fig 8

Combination (6 x 6) response profiles for compound 8, 6, and 3 in JHH-136 (A) and JHH-520 (B) cells. Each response profile is displayed as heatmaps of cell viability (percent response normalized to thapsigargin control; left panels) and DBSumNeg analysis (right panels).